Annual report pursuant to Section 13 and 15(d)

CONSOLIDATED STATEMENTS OF OPERATIONS

v3.22.0.1
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
shares in Thousands, $ in Thousands
 12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Revenues    
Total revenues $ 112,408 $ 16,470
Cost of sales    
Total cost of sales 94,115 31,519
Gross profit/(loss) 18,293 (15,049)
Operating expenses    
Research and development 68,131 43,136
Sales and marketing 47,995 13,136
General and administrative 78,041 20,734
In-process research and development assets acquired 25,581  
Total operating expenses 219,748 77,006
Loss from operations (201,455) (92,055)
Change in fair value of warrant liability (56,576) 56,417
Interest expense (149) (328)
Interest and other (expense) income, net (11,822) 1,011
Loss before income taxes (270,002) (34,955)
Income tax benefit 29,668 940
Net loss $ (240,334) $ (34,015)
Net loss per share-Basic $ (0.92) $ (0.22)
Net loss per share-Diluted $ (0.92) $ (0.22)
Weighted average shares outstanding basic 260,770 157,906
Weighted average shares outstanding diluted 260,770 157,906
Products    
Revenues    
Total revenues $ 105,994 $ 13,718
Cost of sales    
Total cost of sales 87,450 26,945
Services    
Revenues    
Total revenues 6,414 2,752
Cost of sales    
Total cost of sales $ 6,665 $ 4,574